Antony James O’Regan


Tony is head of operations for HB Biotechnology.  Tony joined Harper Bernays in September 2002, as a Senior Research Analyst. Since that time, Tony has progressed to playing a larger role in both the company’s funds management and client relations and was appointed to the Harper Bernays Board in September 2015 and as Chief Operating Officer in February 2018.

He was previously employed as an Analyst/Portfolio Manager at Aberdeen Asset Management, formerly known as Equitilink Australia Limited. Prior to this, Tony also practised briefly as a Solicitor.

Tony has a Bachelor of Economics and a Bachelor of Laws from Monash University.